These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2507217)

  • 1. Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci.
    Jones RN; Gardiner RV
    Diagn Microbiol Infect Dis; 1989; 12(3):271-3. PubMed ID: 2507217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.
    Shungu DL; Weinberg E; Cerami AT
    J Clin Microbiol; 1985 Jun; 21(6):875-9. PubMed ID: 3859487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.
    Zabransky RJ; Bayola-Mueller L; Jenkins SG; Pitkin DR; Schreckenberger PC; Celig DM; Spiegel CA
    J Clin Microbiol; 1990 Dec; 28(12):2804-5. PubMed ID: 2280013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates.
    Ravizzola G; Pinsi G; Gonzales R; Colombrita D; Pirali F; Turano A
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1053-61. PubMed ID: 2620673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sensititre broth microdilution and agar dilution susceptibility testing techniques for meropenem to determine accuracy, reproducibility, and predictive values.
    Dowzicky MJ; Nadler HL; Sheikh W
    J Clin Microbiol; 1994 Sep; 32(9):2204-7. PubMed ID: 7814547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of anaerobic bacteria to meropenem.
    Nord CE; Lindmark A; Persson I
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Clin Lab Med; 1989 Jun; 9(2):239-54. PubMed ID: 2659243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.
    Toohey KL; Kurzynski TA; Schell RF; Birk RJ; Zabransky RJ
    J Clin Microbiol; 1986 Mar; 23(3):619-21. PubMed ID: 3958150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro susceptibility testing of anaerobes with 10-micrograms imipenem discs.
    Meijer-Severs GJ; van Santen E
    J Antimicrob Chemother; 1987 Sep; 20(3):456. PubMed ID: 3479418
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
    Sheikh W; Pitkin DH; Nadler H
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S361-6. PubMed ID: 8324148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing inoculum for susceptibility testing of anaerobes.
    Swenson JM; Thornsberry C
    J Clin Microbiol; 1984 Mar; 19(3):321-5. PubMed ID: 6715509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya.
    Slaney L; Chubb H; Mohammed Z; Ronald A
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():183-6. PubMed ID: 2509415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
    Pitkin DH; Sheikh W; Nadler H
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():251-8. PubMed ID: 2808211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
    Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
    BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Woodford N; Ison CA
    J Antimicrob Chemother; 1988 Oct; 22(4):463-71. PubMed ID: 3144523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two broth disk methods for antibiotic susceptibility testing of anaerobes.
    Helstad AG; Hutchinson MA; Amos WP; Kurzynski TA
    Antimicrob Agents Chemother; 1984 Oct; 26(4):601-3. PubMed ID: 6517551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.